Results 121 to 130 of about 1,258 (160)
Some of the next articles are maybe not open access.
Cyclophosphamide in treatment of tumefactive multiple sclerosis
Multiple Sclerosis and Related Disorders, 2021. To review the Mayo clinic experience of cyclophosphamide in the treatment of tumefactive Multiple Sclerosis (TMS).. Retrospective chart review was performed to identify patients with TMS who did not respond to corticosteroid and plasma exchange and were treated with cyclophosphamide.
Mahboobeh Fereidan-Esfahani +1 more
openaire +2 more sources
Relapsing-remitting tumefactive multiple sclerosis
Multiple Sclerosis Journal, 2005Tumefactive multiple sclerosis (MS) is a rare form of demyelinating disease. The natural course of the disease has been characterized as presenting with a mass-like demyelinating lesion converting to typical relapsing-remitting disease with future exacerbations.
Stephen M, Selkirk, Jiong, Shi
openaire +2 more sources
Late-onset tumefactive multiple sclerosis
Radiation Medicine, 2008A patient with tumefactive multiple sclerosis (MS) initially presented at the age of 87 years; the revised diagnostic criteria from the International Panel on MS (2001) were fulfilled. Late-onset MS and tumefactive demyelinating lesions are discussed. This case suggests that MS can occur at any age. MS should be borne in mind for differential diagnosis
Taizo, Takeuchi +8 more
openaire +2 more sources
Focal Hyperhidrosis in Tumefactive Multiple Sclerosis
Archives of Neurology, 2010No abstract ...
Iorio, Raffaele +7 more
openaire +4 more sources
Bilateral Tumefactive Multiple Sclerosis Lesions
Rivista di Neuroradiologia, 2005Tumefactive lesions are a rare form of multiple sclerosis (MS) presentation often provoking a diagnostic dilemma with brain tumour or abscess. We describe two cases of tumefactive demyelinating MS plaques and two different approaches. In the first patient the clinical and laboratory findings were consistent with MS, a diagnosis supported by the rapid ...
A. Haritanti +7 more
openaire +1 more source
Tumefactive multiple sclerosis and fingolimod
Neurology, 2013Our knowledge of the substantial complexities of the immune system and understanding of the immunopathogenesis of autoimmune diseases are increasing at such a rapid pace that it is impossible for the non-immunologist to stay abreast of the field. However, there are 2 general principles that are important for clinicians to keep in mind.
Friedemann, Paul, Dennis, Bourdette
openaire +2 more sources
Tumefactive Multiple Sclerosis Masquerading as High Grade Glioma
World Neurosurgery, 2018Tumefactive multiple sclerosis is a demyelinating lesion that can radiographically mimic high-grade gliomas during acute episodes, thus affecting clinical decision making. A delay in appropriate diagnoses can result in unnecessary invasive resections. The following case is a patient with unilateral weakness and radiologic findings that were concerning ...
Michelle, Lin +2 more
openaire +2 more sources
Physiologic MRI of a tumefactive multiple sclerosis lesion
Neurology, 1998Structural and physiologic MRI were performed after subacute onset of left hemiparesis in a patient with MS. MRI showed a large ring-enhancing lesion with surrounding edema and mass effect; differential diagnosis included a neoplasm or a large MS plaque.
T, Ernst, L, Chang, I, Walot, K, Huff
openaire +2 more sources
18F-FDG PET/CT in Tumefactive Multiple Sclerosis
Clinical Nuclear Medicine, 2014A 35-year-old man underwent contrast-enhanced MRI and F-FDG PET/CT for acute peripheral paresthesia, vision loss, muscle weakness, and difficulty walking. T2-weighted MRI demonstrated multiple bright periventricular supratentorial and infratentorial white matter lesions, including 2 with nodularity. Both nodular lesions showed moderate focal FDG uptake
Anna Margherita, Maffione +5 more
openaire +2 more sources